1. Home >
  2. Companies >
  3. Private >
  4. Life Science >
  5. United States >
  6. New Jersey >
  7. Janssen Pharmaceuticals >
  8. M&A

Janssen Pharmaceuticals Mergers & Acquisitions

Janssen Pharmaceuticals M&A Summary

Janssen Pharmaceuticals has acquired 5 companies. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets.

Janssen Pharmaceuticals’ largest acquisition to date was in 2019, when it acquired XBiotech - Novel Antibody Bermekimab for $750M. It’s largest disclosed sale occurred in 2011, when it sold Ortho Dermatologics to Bausch Health Companies for $345M. Janssen Pharmaceuticals has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity7
    • M&A Buy Activity4
    • M&A Sell Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 7

Janssen Pharmaceuticals, Inc.

1125 Trenton-Harbourton Road P.O. Box 200,
Titusville, New Jersey 08560
United States,
(609)730-2000
www.janssenpharmaceuticalsinc.com

All (7) Buy (4) Sell (3)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2019-12-07 XBiotech, Inc. - Novel Antibody Bermekimab · Life Science
Austin, Texas

XBiotech, Inc.'s Novel Antibody Bermekimab provides disease-causing inflammation in a wide range of medical conditions.

750 Divestiture

Janssen Pharmaceuticals, Inc.

XBiotech


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal